David Lemus

David Lemus is the founder of Lemax LLC.
Current jobs include Independent Non-Executive Director at Silence Therapeutics Plc since 2018, Director at Pharmaceutical Manufacturers Association of America, Treasurer & Non-Executive Director at Biohealth Innovation, Inc. since 2014, Director, Chief Operating & Financial Officer at miRecule, Inc. since 2022, Chief Financial Officer at Ironshore Pharmaceuticals (America), Inc., and Trustee at Mit Club of Washington Dc.
Former jobs include Chief Executive Officer at Leadiant Biosciences, Inc. from 2013 to 2015, Chief Executive Officer at Ironshore Pharmaceuticals, Inc. from 2020 to 2022, Director at Axela, Inc., Independent Director at Scilex Holding Co. from 2022 to 2024, Independent Director at Scilex, Inc. in 2022, Independent Non-Executive Director at Sorrento Therapeutics, Inc., Treasury Consultant at Electrolux AB, Group Treasurer at Chocoladefabriken Lindt & Sprüngli AG, Chief Operating & Financial Officer at MediGene AG from 2016 to 2017, Chief Financial Officer & Executive Vice President at MorphoSys AG from 1998 to 2011, Chief Executive & Financial Officer at Medigene, Inc., Chief Operating & Financial Officer at Proteros biostructures GmbH from 2017 to 2018, and Manager-Pharma International Division Operations at Hoffman-La Roche, Inc. Education includes graduate degrees from Massachusetts Institute of Technology and MIT Sloan School of Management (1988), and an undergraduate degree from the University of Maryland (1984).